MMMathieu Maisani

Mathieu Maisani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mathieu Maisani has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Camille Ehret

    Inserm U1026, Tissue Bioengineering, University of Bordeaux, 33076 Bordeaux, France

    1 shared publication
  • Diego Mantovani

    Laboratory for Biomaterials and Bioengineering, Canada Research Chair Tier I for the Innovation in Surgery, Department of Min-Met-Materials Engineering and Regenerative Medicine, CHU de Quebec Research Center, Laval University, Quebec City, QC, Canada

    1 shared publication
  • Hugo Oliveira

    BioTis – Tissue Bioengineering Laboratory Université de Bordeaux INSERM U1026 Bordeaux France

    1 shared publication
  • Jean‐François Le Meins

    Laboratoire de Chimie des Polymères Organiques LCPO (UMR5629)-Ecole Nationale Supérieure de Chimie, de Biologie et de Physique (ENSCBP), Institut Polytechnique de Bordeaux, Talence, France

    1 shared publication
  • Joëlle Amédée

    Laboratoire de Bioingénierie Tissulaire (BioTis), INSERM U1026, Université de Bordeaux, 33076 Bordeaux, France

    1 shared publication
  • Lucie Levesque

    Lab. for Biomaterials & Bioengineering (CRC-I), Dept. Min-Met-Materials Engineering & Research Center CHU de Québec, Laval University, Québec City, Canada

    1 shared publication

Latest Publications

  • A new composite hydrogel combining the biological properties of collagen with the mechanical properties of a supramolecular scaffold for bone tissue engineering

    by Mathieu Maisani, Sophia Ziane, Camille Ehret, Lucie Levesque, Robin Siadous, Jean‐François Le Meins, Pascale Chevallier, Philippe Barthélémy, Hugo De Oliveira, Joëlle Amédée, et al.

    Tissue engineering is a promising alternative to autografts, allografts, or biomaterials to address the treatment of severe and large bone lesions. Classically, tissue engineering products associate a scaffold and cells and are implanted or injected into the lesion. These cells must be embedded in an appropriate biocompatible scaffold, which offers a favourable environment for their survival and differentiation. Here, we designed a composite hydrogel composed of collagen I, an extracellular matrix protein widely used in several therapeutic applications, which we associated with a physical hydrogel generated from a synthetic small amphiphilic molecule. This composite showed improved mechanical and biological characteristics as compared with gels obtained from each separate compound. Incorporation of the physical hydrogel prevented shrinkage of collagen and cell diffusion out of the gel and yielded a gel with a higher elastic modulus than those of gels obtained with each component alone. The composite hydrogel allowed cell adhesion and proliferation in vitro and long‐term cell survival in vivo. Moreover, it promoted the differentiation of human adipose‐derived stem cells in the absence of any osteogenic factors. In vivo, cells embedded in the composite gel and injected subcutaneously in immunodeficient mice produced lamellar osteoid tissue and differentiated into osteoblasts. This study points this new composite hydrogel as a promising scaffold for bone tissue engineering applications.